13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 40 holding rows worth $853,604,447.
- Accession
- 0001172661-23-000949
- Filer
- CIK 1792126
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 40 entries on the cover page, a total value of $853,604,447 stated on the cover page (in dollars after the unit check, H1), rows summing to $853,604,447 with VALUE read as dollars as filed, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 3,900,000 | $70,863,000 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 1,350,000 | $69,808,500 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,500,000 | $68,730,000 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 3,150,000 | $55,912,500 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 5,286,666 | $44,513,728 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 1,435,000 | $42,476,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 900,000 | $35,487,000 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 1,500,000 | $32,115,000 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 150,000 | $29,475,000 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,000,000 | $29,210,000 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 2,797,501 | $28,702,360 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 500,000 | $28,535,000 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 220,000 | $28,507,600 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 2,349,600 | $26,479,992 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,150,000 | $24,918,500 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 400,000 | $21,920,000 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 657,016 | $21,543,555 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 1,400,000 | $20,720,000 | dollars as filed | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 660,000 | $20,592,000 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 60,000 | $17,415,000 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 750,000 | $14,677,500 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 2,000,000 | $14,560,000 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 864,960 | $12,879,254 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,100,000 | $12,716,000 | dollars as filed | |
| GERON CORP | 374163103 | COM | 4,000,000 | $9,680,000 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,743,875 | $9,172,494 | dollars as filed | |
| FIBROGEN INC | 31572Q808 | COM | 525,000 | $8,410,500 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 260,000 | $8,200,400 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,250,000 | $7,837,500 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 250,000 | $7,747,500 | dollars as filed | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 180,000 | $6,838,200 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 285,000 | $5,514,750 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 50,000 | $5,500,000 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 200,000 | $3,960,000 | dollars as filed | |
| MORPHOSYS AG | 617760202 | ADR | 900,000 | $3,222,000 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 188,390 | $2,354,875 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 1,000,000 | $1,097,400 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 110,856 | $842,506 | dollars as filed | |
| LIANBIO ADR | 53000N108 | COM | 280,000 | $459,200 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 66,666 | $9,633 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-23-000949 | this filing | 2023-02-14 | acceptance time not in the bulk data set |